Document Classification

Section Type: RESULTS

Text: However, data from the intention-to-treat population suggest that patients in the amlodipine/benazepril group may have better metabolic outcomes than those in the valsartan/hydrochlorothiazide group ; specifically, a preservation of the estimated glomerular filtration rate (5. 7 mL/min/1. 73 m (2) [95 % CI, 1. 9 to 9. 6] ; P = 0. 004) and improvements in glycosylated hemoglobin (-0. 5 % [95 % CI, -0. 7 to -0. 2] ; P < 0. 001), fasting triglycerides (-0. 4 mmol/L [95 % CI, -0. 7 to -0. 2] ; P = 0. 002), HDL-C (0. 07 mmol/L [95 % CI, 0. 01 to 0. 12] ; P = 0. 022), and uric acid (-57. 5 mol/L [95 % CI, -74. 8 to -40. 3] ; P < 0. 001).